273 related articles for article (PubMed ID: 18783295)
21. Pharmacokinetics of ceftazidime and cefepime in burn patients: the importance of age and creatinine clearance.
Conil JM; Georges B; Lavit M; Seguin T; Tack I; Samii K; Chabanon G; Houin G; Saivin S
Int J Clin Pharmacol Ther; 2007 Oct; 45(10):529-38. PubMed ID: 17966838
[TBL] [Abstract][Full Text] [Related]
22. Pharmacodynamics of mivacurium chloride in 13- to 18-yr-old adolescents with thermal injury.
Martyn JA; Chang Y; Goudsouzian NG; Patel SS
Br J Anaesth; 2002 Oct; 89(4):580-5. PubMed ID: 12393359
[TBL] [Abstract][Full Text] [Related]
23. Aztreonam pharmacokinetics in burn patients.
Friedrich LV; White RL; Kays MB; Brundage DM; Yarbrough D
Antimicrob Agents Chemother; 1991 Jan; 35(1):57-61. PubMed ID: 2014982
[TBL] [Abstract][Full Text] [Related]
24. Ciprofloxacin pharmacokinetics in burn patients.
Garrelts JC; Jost G; Kowalsky SF; Krol GJ; Lettieri JT
Antimicrob Agents Chemother; 1996 May; 40(5):1153-6. PubMed ID: 8723457
[TBL] [Abstract][Full Text] [Related]
25. Cisatracurium-induced neuromuscular blockade is affected by chronic phenytoin or carbamazepine treatment in neurosurgical patients.
Richard A; Girard F; Girard DC; Boudreault D; Chouinard P; Moumdjian R; Bouthilier A; Ruel M; Couture J; Varin F
Anesth Analg; 2005 Feb; 100(2):538-544. PubMed ID: 15673889
[TBL] [Abstract][Full Text] [Related]
26. [Retrospective cohort study on the correlation between high value of lactic acid and risk of death in 127 patients with extensive burn during shock stage].
Ding XB; Chen J; Yang YT; Peng X; Yan H; Peng YZ
Zhonghua Shao Shang Za Zhi; 2019 May; 35(5):326-332. PubMed ID: 31154729
[No Abstract] [Full Text] [Related]
27. Ceftazidime dosage recommendations in burn patients: from a population pharmacokinetic approach to clinical practice via Monte Carlo simulations.
Conil JM; Georges B; Ravat F; Ruiz S; Seguin T; Metsu D; Fourcade O; Saivin S
Clin Ther; 2013 Oct; 35(10):1603-12. PubMed ID: 24094465
[TBL] [Abstract][Full Text] [Related]
28. Thermal injury induces greater resistance to d-tubocurarine in local rather than in distant muscles in the rat.
Ibebunjo C; Martyn JA
Anesth Analg; 2000 Nov; 91(5):1243-9. PubMed ID: 11049916
[TBL] [Abstract][Full Text] [Related]
29. Severe burn injury, burn shock, and smoke inhalation injury in small animals. Part 1: burn classification and pathophysiology.
Vaughn L; Beckel N
J Vet Emerg Crit Care (San Antonio); 2012 Apr; 22(2):179-86. PubMed ID: 23016809
[TBL] [Abstract][Full Text] [Related]
30. Calcium antagonists. Drug interactions of clinical significance.
Rosenthal T; Ezra D
Drug Saf; 1995 Sep; 13(3):157-87. PubMed ID: 7495502
[TBL] [Abstract][Full Text] [Related]
31. A prospective study evaluating tobramycin pharmacokinetics and optimal once daily dosing in burn patients.
Lee C; Walker SAN; Walker SE; Seto W; Simor A; Jeschke M
Burns; 2017 Dec; 43(8):1766-1774. PubMed ID: 28647460
[TBL] [Abstract][Full Text] [Related]
32. Neuromuscular effects of mivacurium in 2- to 12-yr-old children with burn injury.
Martyn JA; Goudsouzian NG; Chang Y; Szyfelbein SK; Schwartz AE; Patel SS
Anesthesiology; 2000 Jan; 92(1):31-7. PubMed ID: 10638896
[TBL] [Abstract][Full Text] [Related]
33. The clinical pharmacokinetics of levofloxacin.
Fish DN; Chow AT
Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic origin of carbamazepine-induced resistance to vecuronium neuromuscular blockade in anesthetized patients.
Alloul K; Whalley DG; Shutway F; Ebrahim Z; Varin F
Anesthesiology; 1996 Feb; 84(2):330-9. PubMed ID: 8602663
[TBL] [Abstract][Full Text] [Related]
35. Population pharmacokinetics of imipenem in burn patients.
Dailly E; Kergueris MF; Pannier M; Jolliet P; Bourin M
Fundam Clin Pharmacol; 2003 Dec; 17(6):645-50. PubMed ID: 15015709
[TBL] [Abstract][Full Text] [Related]
36. Cyclosporine exposure and calcineurin phosphatase activity in living-donor liver transplant patients: twice daily vs. once daily dosing.
Fukudo M; Yano I; Masuda S; Katsura T; Ogura Y; Oike F; Takada Y; Tanaka K; Inui K
Liver Transpl; 2006 Feb; 12(2):292-300. PubMed ID: 16447186
[TBL] [Abstract][Full Text] [Related]
37. The influence of renal function on the pharmacokinetics and pharmacodynamics and simulated time course of doxacurium.
Fisher DM; Reynolds KS; Schmith VD; Hsu J; Sokoll MD; Lennon RL; Caldwell JE
Anesth Analg; 1999 Sep; 89(3):786-95. PubMed ID: 10475326
[TBL] [Abstract][Full Text] [Related]
38. Use of nondepolarizing neuromuscular blocking agents in mechanically ventilated patients.
Buck ML; Reed MD
Clin Pharm; 1991 Jan; 10(1):32-48. PubMed ID: 1825627
[TBL] [Abstract][Full Text] [Related]
39. Wide variation in single, daily-dose aminoglycoside pharmacokinetics in patients with burn injuries.
Hoey LL; Tschida SJ; Rotschafer JC; Guay DR; Vance-Bryan K
J Burn Care Rehabil; 1997; 18(2):116-24. PubMed ID: 9095420
[TBL] [Abstract][Full Text] [Related]
40. [Effect of carbachol on intestinal mucosa blood flow and absorption rate of glucose-electrolyte solution during enteral resuscitation for 50% total body surface area full-thickness burn injury in dog].
Hu S; Che JW; Du Y; Bao CM; Tian YJ; Wang L; Geng SJ; Wu J; Sheng ZY
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Mar; 20(3):167-71. PubMed ID: 18328131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
